Stay informed and connected with what’s going on at WBA by catching the latest company stories and videos.
Walgreens Boots Alliance Commits $350,000 to Help Address Critical COVID-19 Needs in India
To help address the critical need for COVID-19-related resources during a surge in cases and deaths in India, WBA today announced a commitment of US $350,000 to the American India Foundation (AIF).
DEERFIELD, Ill., May 7, 2021 – To help address the critical need for COVID-19-related resources during a surge in cases and deaths in India, Walgreens Boots Alliance, Inc. (Nasdaq: WBA) today announced a commitment of US$350,000 to the American India Foundation (AIF).
For a total of $350,000 or more, WBA will:
- provide a direct donation of $100,000 allow its team members to donate to a special fund, amounting to at least $100,000 match these contributions from team members, up to $100,000 contribute an in-kind product donation of approximately $50,000 worth of pulse oximeters
“Throughout the pandemic, WBA has been committed to keeping communities safe and providing much-needed healthcare services, while also working to address barriers to access,” said Rosalind Brewer, CEO, Walgreens Boots Alliance. “Our thoughts are with everyone in India right now, and we are proud to support the American India Foundation to deliver immediate and vital resources at this critical time.”
The contributions to AIF build on WBA’s extensive response efforts throughout the pandemic in thousands of communities around the world, including providing access to COVID-19 testing across more than 6,000 Walgreens and Boots stores, administering more than 15 million COVID-19 vaccines and continually offering the latest health information and resources.
ENDS
Notes to Editors:
About Walgreens Boots Alliance
Walgreens Boots Alliance (Nasdaq: WBA) is a global leader in retail and wholesale pharmacy, touching millions of lives every day through dispensing and distributing medicines, and through its convenient retail locations, digital platforms and health and beauty products. The company has more than 100 years of trusted health care heritage and innovation in community pharmacy and pharmaceutical wholesaling.
Including equity method investments, WBA has a presence in more than 25 countries, employs more than 450,000 people and has more than 21,000 stores.
WBA’s purpose is to help people across the world lead healthier and happier lives. The company is proud of its contributions to healthy communities, a healthy planet, an inclusive workplace and a sustainable marketplace. WBA is a participant of the United Nations Global Compact and adheres to its principles-based approach to responsible business.
WBA is included in FORTUNE’s 2021 list of the World’s Most Admired Companies*. This is the 28th consecutive year that WBA or its predecessor company, Walgreen Co., has been named to the list.
More company information is available at www.walgreensbootsalliance.com.
*© 2021, Fortune Media IP Limited. Used under license.
(WBA-GEN)
Media Relations
Contact
USA / Jim Cohn
International
+1 224 813 9057
+44 (0)20 7980 8585
Investor Relations
Contact
Gerald Gradwell and Jay Spitzer
+1 847 315 2922
Cautionary Note Regarding Forward-Looking Statements: All statements in this release that are not historical are forward-looking statements made pursuant to the safe harbor provisions of the Private Securities Litigation Reform Act of 1995. These forward-looking statements are not guarantees of future performance and involve risks, assumptions and uncertainties, including those described in Item 1A (Risk Factors) of our Form 10-K for the fiscal year ended Aug. 31, 2020, our Quarterly Report on Form 10-Q for the fiscal quarter ended Nov. 30, 2020 and in other documents that we file or furnish with the Securities and Exchange Commission. Should one or more of these risks or uncertainties materialize, or should underlying assumptions prove incorrect, actual results may vary materially. These forward-looking statements speak only as of the date they are made. We do not undertake, and expressly disclaim, any duty or obligation to update publicly any forward-looking statement after the date of this release, whether as a result of new information, future events, changes in assumptions or otherwise.
